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Indigenous microflora: Paving the way for pathogens?
David B. Schauer
Indigenous intestinal microflora are known to afford
protection against colonization by pathogenic
microorganisms. However, the metabolic activity of at
least one species of the indigenous microflora can
induce expression of surface glycoconjugates, which
may in turn confer susceptibility to infection.
Address: Division of Toxicology and Division of Comparative Medicine,
Massachusetts Institute of Technology, Cambridge, Massachusetts
02139, USA.
Electronic identifier: 0960-9822-007-R0075
Current Biology 1997, 7:R75–R77
© Current Biology Ltd ISSN 0960-9822
The interface between a mammalian host organism and
the microflora in its intestinal lumen is the mucous gel
layer and the underlying cell coat, or glycocalyx, of glyco-
conjugates on the apical surface of the epithelium.
Oligosaccharides within this interface can serve as recep-
tors for the attachment of microorganisms. The first chal-
lenge to would-be luminal pathogens is successful
attachment to this surface. The presence of indigenous
intestinal microflora is known to interfere with coloniza-
tion by pathogens, and competition for binding sites is
likely to play a role in this protection. It is now apparent
that the presence of indigenous intestinal microflora can
also influence the expression of glycoconjugates by host
epithelial cells. 
A recent paper by Bry et al. [1] reports that host epithelial
cells express specific glycoconjugates in response to the
presence of bacteria that are able to utilize the sugars that
make up the oligosaccharide units of these macromole-
cules. It seems that pathogenic microorganisms have
evolved to exploit the otherwise mutually beneficial cross-
talk between indigenous microflora and the host by
attaching to these glycoconjugates. This has significance
for the use of model systems to study infectious diseases,
as well as for strategies to prevent and to treat gastroin-
testinal disease.
Many of the studies of indigenous intestinal microflora
have used laboratory mice. A combination of birth by
cesarean section and isolation in a sterile environment
produces mice that are germ-free. Compared to germ-free
mice, conventional mice — which are maintained in asso-
ciation with a normal microflora — are more resistant to
colonization by bacterial pathogens [2]. This colonization
resistance, or bacterial interference, involves competition
for binding sites and for nutrients. It is also known that
short-chain fatty acids, produced by obligate anaerobic
bacteria in the cecum, interfere with colonization by
facultative anaerobes, such as Salmonella enteritidis [3].
The orderly acquisition of microflora in the gut of
conventional mice from birth to adulthood [4] is a further
manifestation of colonization resistance. The initial colo-
nization of the large intestine of suckling mice is by facul-
tative anaerobic coliforms and by enterococci. The
population density of these organisms peaks during the
second week of life. At this time, however, the number of
obligate anaerobes begins to increase, and by 14 days of
age, the number of coliforms and enterococci begins to
fall. By 21 days of age, the adult pattern, in which obligate
anaerobes outnumber coliforms and enterococci by a
factor of 1 000, is established.
The expression of glycoconjugates by gut epithelial cells
has been examined as a function of the presence or
absence of indigenous microflora, and of age, during the
first three weeks of life, the critical period of bacterial suc-
cession. Germ-free mice do not express fucosylated asialo
GM1 glycolipid, but it is expressed by ex-germ-free mice
after they have been reconstituted with the indigenous
microflora of conventional animals [5]. In general, suckling
rodents — those up to 21 days of age — express abundant
sialic-acid-containing glycoproteins, but little fucose-con-
taining glycoproteins. The pattern is reversed, with abun-
dant fucose and little sialic acid content, at weaning (after
21 days of age) [6]. These observations are consistent with
the idea that obligate anaerobic, indigenous microflora
induce expression of fucosylated glycoconjugates by gut
epithelial cells. The results reported by Bry et al. [1] have
confirmed and extended this hypothesis.
By using affinity histochemistry with fucose-specific
lectins, Bry et al. [1] have documented a developmental
pattern of fucosylated glycoconjugate expression in mice.
During the first three weeks of life, fucose residues are
present on scattered mucus-producing goblet cells, and
occasionally cover the entire surface of individual villi in
the small intestine. In conventional mice, a broad band of
cells that express fucosylated glycoconjugates migrates up
each villus, such that, by four weeks of age, the entire
crypt–villus axis expresses fucosylated glycoconjugates
(with increasing expression from the proximal to the distal
end of the small intestine). In germ-free mice, however,
the expression of fucosylated glycoconjugates is extin-
guished, and by four weeks of age only the Paneth cells in
the base of the crypts of Lieberkühn express fucosylated
glycoconjugates.
To determine the role of indigenous microflora in the
developmental pattern of fucosylated glycoconjugate
expression, Bry et al. [1] produced ex-germ-free mice by
reconstituting them with a pure culture of Bacteroides
thetaiotaomicron, an obligate anaerobe and a component of
the indigenous microflora of the human colon. These ex-
germ-free animals exhibit the same pattern of fucosylated
glycoconjugate expression seen in conventional mice.
Interestingly, when ex-germ-free mice are generated by
reconstitution with an isogenic mutant of B. thetaiotaomi-
cron that is unable to utilize L-fucose (or D-arabinose) as a
carbon source, the mice fail to exhibit this pattern of fuco-
sylated glycoconjugate expression. The association
between induced glycoconjugate expression and fucose
utilization suggests that the fucosylated glycoconjugates
provide a source of nutrients for the bacteria.
That the host animal expresses glycoconjugates to provide
nutrients in response to the presence of at least one
species of the indigenous microflora is an attractive
hypothesis. Bry et al. [1] rightly point out that such
regulation of fucosylated glycoconjugate expression by B.
thetaiotaomicron may influence the ability of other compo-
nents of the indigenous microflora to establish a stable
niche. Such regulation may also influence the susceptibil-
ity of the host to intestinal colonization by pathogenic
microorganisms (Fig. 1). 
Several key questions remain unanswered, however. First,
is this host–microbe relationship mutually beneficial?
Specifically, does the presence of B. thetaiotaomicron,
which does not appear to bind to the epithelial cell
surface, contribute to colonization resistance? Second,
what is the relevance of inducible fucosylated glycoconju-
gate expression in the small intestine? In the study by Bry
et al. [1], expression of fucosylated glycoconjugates in the
large intestine was not affected by the presence or the
absence of indigenous microflora. The authors did not
comment on the expression of fucosylated glycoconju-
gates in the stomach. Third, how general is the relation-
ship? Can other species of the indigenous microflora
induce expression of fucosylated glycoconjugates? Can it
be induced by pathogenic microorganisms? These ques-
tions may be particularly relevant for the spiral-shaped
bacteria which colonize the surface of the gut.
The spiral-shaped bacteria that inhabit the interface
between the lumen of the gut and the host epithelium are
quite different from either obligate anaerobes or faculta-
tive anaerobes [7]. These highly specialized organisms are
microaerophilic, reflecting the likely conditions in their
natural niche. Their spiral morphology confers on them a
distinct form of motility, and an advantage in the viscous
mucous layer. The behavior of these spiral-shaped
bacteria in the process of bacterial succession in the mouse
has also been studied [2]. Before the emergence of the
facultative anaerobic coliforms and enterococci in the large
intestine, spiral bacteria begin to appear in the mucus of
the suckling mouse. The number of these bacteria
increases, until by the end of the second week of life both
obligate anaerobes and spiral bacteria are found in the
mucus. However, with increasing numbers of anaerobes
during the third week of life, the spiral bacteria do not
decline in number. Rather, a mixture of spiral bacteria and
obligate anaerobes is found in the mucus of the large
intestine of the adult mouse. It is now recognized that
these spiral bacteria are components of the indigenous
microflora; however, it is also clear that, under the
appropriate circumstances, some of these organisms are
pathogenic [8].
One example of an indigenous spiral bacterium with
pathogenic potential is Helicobacter hepaticus [8], which is
related to the human gastric pathogen Helicobacter pylori.
Infection with H. hepaticus appears to be highly prevalent
in mice [9]. Like gastric infection with H. pylori in
humans, intestinal infection with H. hepaticus in mice is
usually subclinical. The virulence factors of H. hepaticus
that contribute to hepatitis and inflammatory bowel
disease are poorly characterized. It may be that attach-
ment to intestinal epithelium is a prerequisite for the
induction of disease. It has been suggested that attach-
ment of H. pylori to gastric mucosa allows for the delivery
of toxins and secreted proteins [10]. Attachment of H.
pylori to cultured epithelial cell lines is necessary for the
induction and the release of pro-inflammatory cytokines.
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Figure 1
The induction of glycoconjugate expression on intestinal epithelium by
indigenous, obligate anaerobic microflora is suggested to confer
susceptibility to colonization and to disease. The diagram depicts the
cross-talk between indigenous, obligate anaerobic bacteria and the
host epithelium. The expression of surface glycoconjugates provides
receptors for the attachment of luminal pathogens, and for the















Importantly, glycoconjugates have been identified as
receptors for the attachment of H. pylori [10]. If spiral bac-
teria such as H. hepaticus also bind to glycoconjugates on
intestinal epithelial cells, then induction of fucosylated
glycoconjugates by indigenous obligate anaerobes may
allow cell contact and bring about the expression of
disease.
In summary, at least one species of the indigenous
microflora can induce expression of fucosylated glycocon-
jugates in the small intestine of the mouse. Such induc-
tion may provide nutrients which contribute to the
establishment of a stable niche for this, and possibly for
other, indigenous microflora. At the same time, however,
these glycoconjugates may provide receptors for the
mucosal attachment of pathogenic microorganisms. These
hypotheses remain untested. It also remains to be deter-
mined if similar changes occur in the large bowel or in the
stomach, and if so which microbes can bring about such
changes. Answers to these questions will lead to a better
understanding of the pathogenesis of gastrointestinal
infections, and hopefully will contribute to the develop-
ment of new strategies for the prevention and treatment of
disease.
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